Kagiyama Koutaro, Ueno Takafumi, Mitsutake Yoshiaki, Yamaji Kazunori, Ishimatsu Takashi, Sasaki Ken-Ichiro, Fukumoto Yoshihiro
Division of Cardiovascular Medicine, Kurume University School of Medicine, Japan.
Intern Med. 2019 Dec 1;58(23):3415-3419. doi: 10.2169/internalmedicine.3272-19. Epub 2019 Jul 31.
In 2018, the CorPath GRX system (Corindus) was approved for use in Japan, marking the introduction of the first robotic-assisted system for percutaneous coronary intervention (PCI) in the country. The present report describes the first experience of robotic-assisted PCI for four coronary lesions in two cases in a single center. All procedures succeeded without any complications, although one procedure was converted to manual PCI by the operator's decision. Post-marketing surveillance to assess the impact of this novel system on both Japanese patients and physicians is currently ongoing in Japan.
2018年，CorPath GRX系统（Corindus公司）在日本获批使用，标志着该国首个用于经皮冠状动脉介入治疗（PCI）的机器人辅助系统问世。本报告描述了在单一中心对两例患者的四个冠状动脉病变进行机器人辅助PCI的首例经验。所有手术均成功完成，无任何并发症，不过有一例手术经操作者决定转为手动PCI。目前日本正在进行上市后监测，以评估这一新型系统对日本患者和医生的影响。
